NCT06915766
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06915766
Title Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Cogent Biosciences, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Orso Health/Modena Asthma Allergy AVAILABLE La Jolla California 92037 United States Details
Indiana University Health AVAILABLE Indianapolis Indiana 46202 United States Details
Walter Reed AVAILABLE Bethesda Maryland 20889 United States Details
AllerVie Health AVAILABLE Glenn Dale Maryland 20769 United States Details
Dana Farber Cancer Institute AVAILABLE Boston Massachusetts 02215 United States Details
Dartmouth-Hitchcock Medical Center AVAILABLE Lebanon New Hampshire 03756 United States Details
Duke Blood Cancer Center AVAILABLE Durham North Carolina 27705 United States Details
The Ohio State University Wexner Medical Center AVAILABLE Columbus Ohio 43210 United States Details
AIR Care AVAILABLE Dallas Texas 75231 United States Details
The University of Texas, MD Anderson Cancer Center AVAILABLE Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field